Skip to main content
Clinical Trials/NCT02466451
NCT02466451
Completed
N/A

Observational Longitudinal Study in Children With the Diagnosis of Diaphragmatic Hernia and/or Oesophageal Atresia for Assessing Lung Function Parameters and Quality of Life

Stefania La Grutta, MD0 sites33 target enrollmentMarch 2014

Overview

Phase
N/A
Intervention
Not specified
Conditions
Diaphragmatic Hernia
Sponsor
Stefania La Grutta, MD
Enrollment
33
Primary Endpoint
Pulmonary Function Test
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Observational longitudinal study in children operated at birth on diaphragmatic hernia and/or oesophageal atresia : assessment of lung function parameters; assessment of quality of life and cognitive development; assessment of stress parenting and strategies of adaptation.

Detailed Description

Observational longitudinal study in children operated at birth on diaphragmatic hernia and/or oesophageal atresia : assessment of lung function parameters; assessment of quality of life and cognitive development; assessment of stress parenting and strategies of adaptation. Tools: Anamnestic-clinical questionnaire, Spirometry, Plethysmography, Fractional exhaled nitric oxide (FeNO) assessment (oral and alveolar ), 6-minutes walk test (WT 6'), Prick tests, Quality of life in children questionnaire(KINDL, quality of life), Psychological test for cognitive development (Raven Matrices)

Registry
clinicaltrials.gov
Start Date
March 2014
End Date
May 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Stefania La Grutta, MD
Responsible Party
Sponsor Investigator
Principal Investigator

Stefania La Grutta, MD

Senior Researcher

Istituto per la Ricerca e l'Innovazione Biomedica

Eligibility Criteria

Inclusion Criteria

  • Children operated at birth on diaphragmatic hernia and/or oesophageal atresia
  • Written informed consent, signed by parents

Exclusion Criteria

  • Children that have had infections in the last 4 weeks
  • Children with ongoing diseases
  • Children that take drugs able to modify the lung function

Outcomes

Primary Outcomes

Pulmonary Function Test

Time Frame: 1 year

Spirometry

Secondary Outcomes

  • Quality of Life(1 year)

Similar Trials